CanSinoBIO's mRNA COVID vaccine candidate cleared for trials in China - Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ALWDSCPFHVL4BPSTQLDFSG5ZDM.jpg)
4/3/2022 12:00:00 AM3 years 10 months ago
Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical products regulator to enter clinical trials.
BEIJING, April 4 (Reuters) - Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by … [+1028 chars]
full article...